Time |
Witness |
8.30 am -9.10 am |
Generic Medicines Industry Association (Submission 8)
Dr Martin Cross, Managing Director, Alphapharm
Mr Roger Millichamp, Managing Director, Apotex
Mr Robert Ellis, General Manager Business Development, Sigma Pharmaceuticals
Ms Kate Lynch, Chief Executive Officer |
9.10 am -9.50 am |
The Pharmacy Guild of Australia (Submission 4)
Ms Toni Riley, Chair, Health Economics Committee
Mr Stephen Armstrong, National Manager, Economic Analysis and e-Health |
9.50 am -10.30 am |
Medicines Australia (Submission 6)
Mr Will Delaat, Chairman
Ms Deborah Waterhouse, General Manager Australia and New Zealand, GlaxoSmithKline Australia
Ms Jane Orr, Managing Director, MSD Australia & New Zealand
Mr Peter Vermeer, Director, Corporate Affairs and Market Access, Eli Lilly
Dr Brendan Shaw, Chief Executive |
10.30 am -10.45 am |
Break |
10.45 am -11.25 am |
Consumers Health Forum (Submission 9)
Ms Carol Bennett, Executive Director
Ms Anna Wise, Senior Policy Manager |
11.25 am -12.05 pm |
National Pharmaceutical Services Association (Submission 3)
Mr Patrick Davies, President and Chief Executive Officer, Symbion Pharmaceuticals
Mr Brett Barons, General Manager – Supply Chain and Strategy, Symbion Pharmaceuticals
Mr Mark Hooper, Chief Executive Officer, Sigma Pharmaceuticals
Ms Pattie Beerens, Executive Director |
12.05 pm -1.05 pm |
Lunch |
1.05 pm -2.20 pm |
Department of Health and Ageing (Submission 31)
Mr David Learmonth, Deputy Secretary
Mr Andrew Stuart, Acting Deputy Secretary
Ms Felicity McNeill, Acting First Assistant Secretary, Pharmaceutical Benefits Division
Ms Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Division, Pharmaceutical Benefits Division
Mr Nick Henderson, Acting Assistant Secretary, Policy and Analysis Branch, Pharmaceutical Benefits Division |